Tariff pressures lead to revenue decline and guidance cut for Teleflex

From StockStory Inc.: 2025-05-14 17:57:00

Teleflex (NYSE:TFX) reported Q1 CY2025 revenue in line with analyst estimates at $700.7 million, a 5% year-on-year decline. Non-GAAP profit of $2.91 per share beat consensus by 0.9%. Full-year adjusted EPS guidance is $13.40, missing estimates by 4.9%. The company cited challenges in OEM and Interventional Urology segments, with strong growth in Vascular Access and Interventional products. Tariffs and macroeconomic pressures led to a downward revision in guidance. Analysts questioned OEM trends, tariff mitigation, and the NewCo sale process. Key focus areas include recovery in OEM and China business, tariff impact, BIOTRONIK integration, and business separation execution.

StockStory highlights the best stocks for high-quality investors amidst market uncertainty. Check out the top 5 strong momentum stocks for durable portfolio building. Past winners like Nvidia and Comfort Systems have shown significant returns. Explore StockStory for your next potential winner in the market.



Read more at StockStory Inc.: Guidance Cut and Strategic Shifts Dominate Amid Tariff Headwinds